A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett’s esophagus (BE) containing dysplasia: interim results of the AIM Dysplasia Trial - Shaheen, N; Sharma, P; Overholt, B (Gastroenterology, 2008)
et al.